← Leaderboards
Steven G Younkin
Mayo Clinic Coll Of Medicine, Rochester
$10,356,719
Attributed
$10,571,906
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2005–17$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$19,059,227 · 7
By mechanism
R01$8,762,254 · 3
U01$8,487,321 · 1
P50$948,902 · 1
R21$860,750 · 2
Top collaborators
- Nilufer Ertekin-Taner9 shared
- Todd E. Golde7 shared
- Nathan D Price7 shared
Most similar at Mayo Clinic Coll Of Medicine, Rochester
Same institution · by research overlap
- Ronald C Petersen$104,627,909
- James R Cerhan$31,221,407
- Edward B Leof$12,689,865
- Jan C Buckner$13,181,861
- James Newell Ingle$11,197,195
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseBrainGenesS Disease RiskVariantProteinsAmyloidPlasmaAllelesGene ExpressionSeriesSamplingGenetic AssociationAgingPhenotypeReportingBaseResearch InfrastructureAffectPre-ClinicalCollaborationsPlayDisease /Disorder Onset
Grant awards (38)
A system approach to targeting innate immunity in AD$1,765,056
U01 · FY2017 · AG
A system approach to targeting innate immunity in AD$1,592,165
U01 · FY2016 · AG
Genetic and Functional Analysis of Nested AD Risk Genes CTNNA3 and LRRTM3$195,625
R21 · FY2016 · AG · contact PI
A system approach to targeting innate immunity in AD$156,500
U01 · FY2016 · AG
A system approach to targeting innate immunity in AD$1,597,190
U01 · FY2015 · AG
Genetic and Functional Analysis of Nested AD Risk Genes CTNNA3 and LRRTM3$234,750
R21 · FY2015 · AG · contact PI
Role of soluble TREM2 and its R47H and D87N variants in neurodegenerative disease$195,625
R21 · FY2015 · NS · contact PI
A system approach to targeting innate immunity in AD$1,665,226
U01 · FY2014 · AG
Role of soluble TREM2 and its R47H and D87N variants in neurodegenerative disease$234,750
R21 · FY2014 · NS · contact PI
A system approach to targeting innate immunity in AD$109,143
U01 · FY2014 · AG
A system approach to targeting innate immunity in AD$1,602,041
U01 · FY2013 · AG
Plasma AB as a Surrogate Genetic Marker for LOAD$297,998
R01 · FY2012 · AG · contact PI
ChAT, AChE, and Cholinergic Neurons in Aging and AD$578,370
R01 · FY2011 · AG · contact PI
Plasma AB as a Surrogate Genetic Marker for LOAD$298,015
R01 · FY2011 · AG · contact PI
ChAT, AChE, and Cholinergic Neurons in Aging and AD$585,182
R01 · FY2010 · AG · contact PI
Plasma AB as a Surrogate Genetic Marker for LOAD$310,063
R01 · FY2010 · AG · contact PI
ChAT, AChE, and Cholinergic Neurons in Aging and AD$586,906
R01 · FY2009 · AG · contact PI
Plasma AB as a Surrogate Genetic Marker for LOAD$317,495
R01 · FY2009 · AG · contact PI
Vasopeptidases and Beta Amyloid Accumulation$136,699
R01 · FY2009 · NS · contact PI
ChAT, AChE, and Cholinergic Neurons in Aging and AD$580,311
R01 · FY2008 · AG · contact PI
Plasma AB as a Surrogate Genetic Marker for LOAD$319,814
R01 · FY2008 · AG · contact PI
Vasopeptidases and Beta Amyloid Accumulation$270,138
R01 · FY2008 · NS · contact PI
Susceptibility Alleles in IDE Region on Chromosome 10$205,240
P50 · FY2008 · AG · contact PI
ChAT, AChE, and Cholinergic Neurons in Aging and AD$612,268
R01 · FY2007 · AG · contact PI
Susceptibility Alleles in IDE Region on Chromosome 10$197,069
P50 · FY2007 · AG · contact PI
SUSCEPTIBILITY ALLELES IN IDE REGION ON CHROMOSOME 10$186,628
P50 · FY2006 · AG · contact PI
PLASMA A BETA AS A SURROGATE GENETIC MARKER FOR LOAD$348,075
R01 · FY2005 · AG
SUSCEPTIBILITY ALLELES IN IDE REGION ON CHROMOSOME 10$182,154
P50 · FY2005 · AG
CHAT, ACHE, AND CHOLINERGIC NEURONS IN AGING AND ALZHEIM$446,515
R01 · FY2004 · AG
PLASMA A BETA AS A SURROGATE GENETIC MARKER FOR LOAD$348,075
R01 · FY2004 · AG
SUSCEPTIBILITY ALLELES IN IDE REGION ON CHROMOSOME 10$177,811
P50 · FY2004 · AG
CHAT, ACHE, AND CHOLINERGIC NEURONS IN AGING AND ALZHEIM$435,811
R01 · FY2003 · AG
PLASMA A BETA AS A SURROGATE GENETIC MARKER FOR LOAD$348,075
R01 · FY2003 · AG
CHAT, ACHE, AND CHOLINERGIC NEURONS IN AGING AND ALZHEIM$425,423
R01 · FY2002 · AG
PLASMA A BETA AS A SURROGATE GENETIC MARKER FOR LOAD$348,075
R01 · FY2002 · AG
CHAT, ACHE, AND CHOLINERGIC NEURONS IN AGING AND ALZHEIM$415,333
R01 · FY2001 · AG
PLASMA A BETA AS A SURROGATE GENETIC MARKER FOR LOAD$348,075
R01 · FY2001 · AG
CHAT, ACHE, AND CHOLINERGIC NEURONS IN AGING AND ALZHEIM$405,538
R01 · FY2000 · AG